|
Press Release
3rd Millennium Implements Bioinformatics System for Ardais Corporation
CAMBRIDGE, MA - December 4, 2001 -- 3rd Millennium, a leading
bioinformatics consultancy based in Cambridge, MA, announced today
the completion of a custom bioinformatics system for Ardais Corporation.
The engagement involved the design and development of a laboratory
information management system (LIMS) to support the unique needs
of Ardais’ high throughput pathology lab operations.
The proprietary
system developed by 3rd Millennium provides the full suite of
standard LIMS functionality along with capabilities to support
the specific integration, workflow, and analysis needs of Ardais’
researchers and biopharmaceutical collaborators. "The system is
central to our BIGR™ Library, through which we provide biomedical
researchers with research-quality clinical materials, accompanied
by in-depth medical, pathology, treatment history and outcomes
data, along with proprietary bioinformatics tools to design their
experiments," said Martin L. Ferguson Ph. D., Ardais' vice president
of Bioinformatics. "3rd Millennium did a great job of designing
a system to handle the complexity of integrating clinical and
bioinformatics information in our high-throughput laboratory setting
– a task that has rarely if ever been done in the world of drug
discovery. Because they work exclusively in this domain, they
were able to understand quickly what we needed the system to do
and they developed it on an aggressive schedule."
"Ardais is a
tremendously exciting company whose technology, services and capabilities
will add significantly to biomedical research,” said Richard Dweck,
president of 3rd Millennium. “In this case, by deploying a team
with considerable medical, biological, and systems development
expertise while leveraging our experience and tools, we were able
to implement a system that should add considerable value to Ardais’
business. Our team really enjoyed working with Ardais. It was
a project that enabled us to work with a rapidly-growing company
and draw on the recent work we did on a number of other systems
we developed."
About Ardais Corporation
Ardais Corporation is
a privately held clinical genomics company headquartered in Lexington,
Massachusetts. Ardais enhances and accelerates drug discovery
by systematically introducing actual human disease into the discovery
research process on a large scale. Ardais BIGRTM Library is a
shared, centralized repository – encompassing tens of thousands
of tissue samples, molecular derivatives and associated clinical
information – that enables researchers to conduct large-scale
molecular analyses of actual human disease, in order to identify
and validate clinically relevant biological targets for potential
pharmaceutical intervention and diagnostic development. Ardais
applies its human disease-based technology platform, integrated
expertise and tissue collection infrastructure to advance the
clinical discovery programs of its biopharmaceutical partners.
For further information, visit the Company’s website at www.ardais.com.
About 3rd Millennium, Inc.
3rd Millennium, Inc., located in Cambridge,
MA is a leading bioinformatics consultancy that works with pharmaceutical,
biotech, and academic clients on a project basis to design and
develop software systems critical to early stage biological research
and discovery. 3rd Millennium's expertise is in custom biological
database applications, microarray informatics and analytics, and
data and analysis integration. The company has extensive experience
developing systems for laboratory information management, microarray-based
gene expression profiling, gene analysis and annotation, genomic
and proteomic data integration and versioning, and biological
pathway modeling. Additional information can be found at www.3rdmill.com.
|